ecancermedicalscience

ecancermedicalscience is an open access cancer journal focused on under-resourced communities. In order to help reduce global inequalities in cancer care and treatment, we provide free access to all articles from the point of publication and we only charge authors who have specific funding to cover publication costs.

The journal considers articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, controlled trials (in particular if they are independent or publicly funded trials), health systems, cancer policy and regulatory aspects of cancer care.

Editor-in-Chief: Dr Enrique Soto Pérez de Celis MD, PhD, FASCO

ISSN: 1754-6605

Submit article

382-locked-in-syndrome-after-basilary-artery-thrombosis-by-mucormycosis-masquerading-as-meningoencephalitis-in-a-lymphoma-patient

Case Report: Locked-in syndrome after basilary artery thrombosis by mucormycosis masquerading as meningoencephalitis in a lymphoma patient

Fausto Maffini, Emilia Cocorocchio, Giancarlo Pruneri, Guido Bonomo, Fedro Peccatori, Laura Chiapparini, Silvia Di Vincenzo, Giovanni Martinelli, Giuseppe Viale

19 Dec 2013

https://doi.org/10.3332/ecancer.2013.382

Abstract | Full Article | PDF

381-progesterone-receptor-isoforms-a-and-b-new-insights-into-the-mechanism-of-progesterone-resistance-for-the-treatment-of-endometrial-carcinoma

Review: Progesterone receptor isoforms A and B: new insights into the mechanism of progesterone resistance for the treatment of endometrial carcinoma

Ruijin Shao

19 Dec 2013

https://doi.org/10.3332/ecancer.2013.381

Abstract | Full Article | PDF

380-the-impact-of-the-oncotype-dx-recurrence-score-on-treatment-decisions-and-clinical-outcomes-in-patients-with-early-breast-cancer-the-maccabi-healthcare-services-experience-with-a-unified-testing-policy

Research: The impact of the Oncotype DX Recurrence Score on treatment decisions and clinical outcomes in patients with early breast cancer: the Maccabi Healthcare Services experience with a unified testing policy

Nava Siegelmann-Danieli, Barbara Silverman, Aviad Zick, Anat Beit-Or, Itzhak Katzir, Avi Porath

17 Dec 2013

https://doi.org/10.3332/ecancer.2013.380

Abstract | Full Article | PDF

379-borderline-tumours-of-the-ovary-current-controversies-regarding-their-diagnosis-and-treatment

Review: Borderline tumours of the ovary, current controversies regarding their diagnosis and treatment

María Guadalupe Patron, Lucas Minig, Ivan Diaz-Padilla, Nuria Romero, Juan Francisco Rodriguez Moreno, Jesus Garcia-Donas

17 Dec 2013

https://doi.org/10.3332/ecancer.2013.379

Abstract | Full Article | PDF | Spanish

378-one-for-the-road-a-study-to-assess-the-efficacy-of-single-low-dose-regimen-of-rasburicase-in-controlling-hyperuricaemia-in-patients-with-tumour-lysis-syndrome-due-to-haematological-malignancies

Case Report: One for the road! A study to assess the efficacy of single low-dose regimen of rasburicase in controlling hyperuricaemia in patients with tumour lysis syndrome due to haematological malignancies

Hamdy A Azim, Sherif Ahmed Bahr, Nermine Shawky Kamal, Mohamed Adel Koura, Rehab Tolba, Heba Abdelmoneem Gad, Ahmad Morsy, Hossameldin Mohsen Attia, Ibraheem Iskander, Ahmed Hammad, Mohammed Farouk Hemed, Mohammed Fathy Abdallah, Kareem Ahmed Sadek, Alaa Hamdi Taha

10 Dec 2013

https://doi.org/10.3332/ecancer.2013.378

Abstract | Full Article | PDF